Is allogeneic stem cell transplantation for transformed follicular lymphoma anti-lymphoma stem cell therapy?

被引：2
|
作者：
Ritchie, David S. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Haematol & Med Oncol, Melbourne, Vic 3002, Australia
来源：
LEUKEMIA & LYMPHOMA | 2008年 / 49卷 / 10期
关键词：
D O I：
10.1080/10428190802491714
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1852 / 1853
页数：2
相关论文
共 50 条
  • [41] Patient Selection and Timing of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Follicular Lymphoma
    Fillon, Mike
    CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (04) : 235 - 236
  • [42] Cicatricial Pemphigoid of the Oropharynx after Allogeneic Stem Cell Transplantation for Relapsed Follicular Lymphoma
    Natalie Collins
    Gary M. Kupfer
    International Journal of Hematology, 2005, 82 (3) : 176 - 183
  • [43] Favourable overall survival with myeloalblative allogeneic stem cell transplantation for follicular lymphoma.
    Kuruvilla, John
    Bao, Qikun
    Messner, Erica
    Gupta, Vikas
    Kiss, Thomas L.
    Lipton, Jeffrey H.
    Minden, Mark D.
    Messner, Hans A.
    BLOOD, 2006, 108 (11) : 852A - 852A
  • [44] Cicatricial Pemphigoid of the Oropharynx after Allogeneic Stem Cell Transplantation for Relapsed Follicular Lymphoma
    Yoshinobu Aisa
    Takehiko Mori
    Tomonori Nakazato
    Rie Yamazaki
    Jun Yamagami
    Masayuki Amagai
    Yasuo Ikeda
    Shinichiro Okamoto
    International Journal of Hematology, 2005, 82 : 266 - 269
  • [45] Favorable overall survival with fully myeloablative allogeneic stem cell transplantation for follicular lymphoma
    Kuruvilla, John
    Pond, Gregory
    Tsang, Richard
    Gupta, Vikas
    Lipton, Jeffrey H.
    Messner, Hans A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (07) : 775 - 782
  • [46] The Impact of Prior Exposure to Rituximab On Autologous Stem Cell Transplantation in Patients with Follicular and Transformed Follicular Lymphoma
    Muccilli, Alexandra D.
    Doucette, Steve
    McDiarmid, Sheryl
    Huebsch, Lothar B.
    Sabloff, Mitchell
    BLOOD, 2009, 114 (22) : 507 - 507
  • [47] Autologous stem cell transplantation versus reduced-intensity allogeneic stem cell transplantation for follicular lymphoma: a matched pair analysis
    Robinson, S. P.
    Canals, C.
    Taghipour, G.
    Attal, M.
    Pagliuca, A.
    Blaise, D.
    Milpied, N.
    Cook, G.
    Jouet, J. -P.
    Finke, J.
    Johnson, P.
    McQuaker, G.
    Delgado, J.
    Pimentel, P.
    Russell, N.
    Sureda, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S2 - S3
  • [48] Tandem autologous stem cell transplantation or non-myeloablative allogeneic stem cell transplantation following autologous stem cell transplantation for transformed low-grade lymphoma
    Dubruille, V
    Morineau, N
    Moreau, P
    Guillaume, T
    Mahe, B
    Chevalier, P
    Harousseau, J
    Milpied, N
    BONE MARROW TRANSPLANTATION, 2004, 33 : S250 - S250
  • [49] Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma
    Hamadani, Mehdi
    Awan, Farrukh T.
    Elder, Patrick
    Lin, Thomas S.
    Porcu, Pierluigi
    Benson, Don M.
    Blum, Kristie A.
    Devine, Steven M.
    LEUKEMIA & LYMPHOMA, 2008, 49 (10) : 1893 - 1898
  • [50] Allogeneic haematopoietic stem cell transplantation in patients with non-transformed follicular lymphoma grades I-IIIA: data provided by the German Registry for Stem Cell Transplantation
    Heinzelmann, F.
    Beelen, D. W.
    Ehninger, G.
    Finke, J.
    Mueller, C.
    Schrezenmeier, H.
    Ottinger, H.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S439 - S439
12345